Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

26.21 +0.38 (+1.47%)
Official Closing Price Updated: 5:00 PM EST, Nov 29, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
99 100 Next >
Crucial Battle Over Healthcare Mandates: Biden Administration Defends Preventive Care Coverage Amidst Legal Challenges
The Biden administration wants insurers to cover preventive care, facing opposition from businesses led by Braidwood Management. 
Via Benzinga
1 S&P 500 Dividend Stock Down 56% to Buy and Hold Forever
The picture for this stock might look bleak, but appearances can be deceiving. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
3 Magnificent Ultra-High-Yield Dividend Stocks That Are Screaming Buys in March
These high-octane income stocks, which sport a scorching-hot average yield of 8.84%, can fatten the wallets of patient investors. 
Via The Motley Fool
Is Novavax a Buy Now?
The stock has dropped 98% over the past three years. 
Via The Motley Fool
BridgeBio, A Top 3% Biotech, Just Snagged A $310 Million Deal; Will Shares Break Out?
BridgeBio will receive a tiered royalty on sales that begins at the low-30% range. 
Via Investor's Business Daily
BNTX DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action - BNTX
WHY: NEW YORK, NY - (NewMediaWire) - March 03, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioNTech SE (NASDAQ: BNTX) between March 30, 2022 and... 
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
Analyst Scoreboard: 9 Ratings For Pfizer
Via Benzinga
This Is What Whales Are Betting On Pfizer
Via Benzinga
BNTX DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action - BNTX
WHY: NEW YORK, NY - (NewMediaWire) - March 03, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioNTech SE (NASDAQ: BNTX) between March 30, 2022 and... 
Via TheNewswire.com
Topics Lawsuit
Exposures COVID-19 Financial Legal
Plan Ahead! 7 Stocks to Buy Before Any Market Downturn Occurs
While red ink in the broader equities space could hurt most entities, these stocks to buy for a market downturn might be resilient. 
Via InvestorPlace
3 Volatility-Busting, Low-Beta Stocks to Grab Now
These are the undervalued low-beta stocks to buy as they represent blue-chip names with robust cash flow outlook. 
Via InvestorPlace
1 Magnificent S&P 500 Dividend Stock Down 56% to Buy and Hold Forever
Investors are so worried about a one-off situation that they're looking right past the bigger bullish picture. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
Hot on the Hedge Funds’ Trail: 3 Stocks Worth Your Bet?
With a 7.1% Q4 leap, hedge fund stocks underscore their role as incredible bets in a well-rounded portfolio. 
Via InvestorPlace
BNTX DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action - BNTX
WHY: NEW YORK, NY - (NewMediaWire) - March 01, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioNTech SE (NASDAQ: BNTX) between March 30, 2022 and... 
Via TheNewswire.com
Topics Lawsuit
Exposures COVID-19 Financial Legal
BNTX DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action - BNTX
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
2 Stocks That Could Turn $1,000 Into $2,500 in 5 Years
It will take a lot, but this goal isn't out of reach for these stocks. 
Via The Motley Fool
3 Overhyped Stocks Every Smart Investor Should Ignore
Learn why smart investors avoid overhyped stocks, highlighting three companies facing significant challenges in today's volatile market. 
Via InvestorPlace
Pfizer Oncology Hosts Innovation Day, Highlighting Fully Integrated Organization, Robust Portfolio, and Strategic Priorities to Drive Long-Term Sustainable Growth
From Pfizer Inc.
Via Business Wire
Pfizer's Respiratory Syncytial Virus Vaccine Maintains Staying Power In Older Adults Through 2nd RSV season, Study Finds
Pfizer reports strong 77.8% efficacy for Abrysvo vaccine against RSV in adults 60+. Durable 88.9% efficacy after two seasons. Consistent protection for RSV A and B. No new adverse events. FY2023 sales... 
Via Benzinga
BNTX IMPORTANT DEADLINE: ROSEN, A LONGSTANDING LAW FIRM, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action - BNTX
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
BNTX IMPORTANT DEADLINE: ROSEN, A LONGSTANDING LAW FIRM, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action - BNTX
WHY: NEW YORK, NY - (NewMediaWire) - February 29, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioNTech SE (NASDAQ: BNTX) between March 30, 2022 and... 
Via TheNewswire.com
Topics Lawsuit
Exposures COVID-19 Financial Legal
Pfizer Announces Positive Top-Line Data for Full Season Two Efficacy of ABRYSVO® for RSV in Older Adults
From Pfizer Inc.
Via Business Wire
3 Starter Long-Term Stocks Every New Investor Should Own
These three long-term stocks for new investors provide a solid foundation, harmonizing risk with rewarding prospects for the long haul. 
Via InvestorPlace
3 Forgotten Dividend Stocks With a Yield of Over 5%
These are the undervalued dividend stocks to buy as they represent fundamentally strong companies poised for accelerated growth. 
Via InvestorPlace
7 Dividend Stocks to Buy to Secure Steady Income
Unlock financial growth with 7 standout dividend stocks in real estate, industrial, pharma, and telecom sectors for long-term success. 
Via InvestorPlace
3 Overextended Stocks That Need to Slash Their Dividends ASAP
The most common attribute of overextended stocks other than carrying too much debt is dividends that are too big. 
Via InvestorPlace
Pfizer Stock Has 30% Upside, According to 1 Wall Street Analyst
Income investors can enjoy the nearly 6% dividend yield even if growth doesn't return. 
Via The Motley Fool
Global Health and Education Projects and Kano Independent Research Centre Trust Sign Strategic Partnership to Support Researchers in Africa
Via AB Newswire
7 Defensive Stocks to Weather Any Downturn With Ease
While circumstances may look favorable in the market, it doesn’t hurt for investors to consider defensive stocks – just in case. 
Via InvestorPlace
3 Blue-Chip Stocks to Buy to Bolster Your Portfolio
Delve into three undervalued blue-chip stocks to buy driving growth in consumer staples, pharmaceuticals, and healthcare. 
Via InvestorPlace
< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.